Skip to main content
. 2018 Mar 16;9(4):381–385. doi: 10.1021/acsmedchemlett.8b00079

Scheme 2. Synthesis of (S)-cHPMPA Phosphonamidates 1016.

Scheme 2

Reagents and conditions: (a) (i) l-amino acid (di)amyl ester HCl salts 9ag (see the Supporting Information), PhOH, 2,2′-dithiodipyridine, PPh3, Et3N, Pyr, 60 °C, 12 h; (ii) TCA (6% in DCM), rt, 2 h, 28–35% over two steps.

HHS Vulnerability Disclosure